The Breast Cancer Prevention Trial: Evaluating Tamoxifen’s Efficacy in Preventing Breast Cancer
Author:
- PhD Valerie Ann McKeon RNCPRPhD Valerie Ann McKeon RNC
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 26 (1) , 79-90
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- CON: The Role of Tamoxifen in Breast Cancer Treatment: Yes Prevention: NoJournal of Women's Health, 1995
- A Risk-Benefit Assessment of Tamoxifen TherapyDrug Safety, 1993
- Tamoxifen for the Primary Prevention of Breast Cancer: A Review and Critique of the Concept and TrialEpidemiologic Reviews, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Bone mineral content of women receiving tamoxifen for mastalgiaBritish Journal of Cancer, 1989
- Reversible ocular toxicity related to tamoxifen therapyCancer, 1988
- Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Tamoxifen treatment of metastatic breast cancer and antithrombin III levelsCancer, 1984
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- ORAL CONTRACEPTIVES AND LOW ANTITHROMBIN-III CONCENTRATIONThe Lancet, 1970